Sutro Biopharma to Host Investor Webcast Highlighting Potential Multi-Cancer Opportunity for Luvelta, a FolR?-targeted ADC, on January 4, 2024
Stock Information for Sutro Biopharma Inc.
Loading
Please wait while we load your information from QuoteMedia.